Logo

Genome Therapeutics Achieves Milestone in Schering-Plough Research

Dec 31, 1999
Premium

W

ALTHAM, Mass.--Genome Therapeutics last month announced that it had reached a milestone in its genomics alliance with Schering-Plough. The genomics company is using its proprietary bioinformatics tools and high-throughput sequencing capacity to identify within a specific chromosomal region candidate genes believed to be involved in the development of asthma. The milestone achievement triggers a payment of an undisclosed amount by Schering to Genome Therapeutics.

Filed under

Informatics
Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.